Phase 2 ACTH Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2
Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome
Cushing s SyndromeACTH
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)80 enrolled1 locationNCT02019706
Not Yet Recruiting
Phase 2
A Multicenter, Phase 2/3, Dose Range Finding Study to Evaluate the Efficacy and Safety of Atumelnant in Adults with ACTH-Dependent Cushing’s syndrome (ADCS) Including an Open-Label Extension for Long-Term Assessment (EQUILIBRIUM ADCS) - Part A
ACTH-Dependent Cushing’s syndrome (ADCS)
Crinetics Pharmaceuticals, Inc.57 enrolled18 locationsACTRN12626000211369
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome
Cushing SyndromeCushing DiseaseEctopic ACTH Syndrome
Crinetics Pharmaceuticals Inc.18 enrolled1 locationNCT05804669